Skip to main content
Zelluna ASA logo

Zelluna ASA — Investor Relations & Filings

Ticker · ULTI ISIN · NO0010851603 LEI · 254900B4VALJZR9TL744 OL Manufacturing
Open in API
Filings indexed 483 across all filing types
Latest filing 2025-07-03 Share Issue/Capital Cha…
Country NO Norway
Listing OL ULTI

About Zelluna ASA

https://www.zelluna.com/

Zelluna ASA is a cell therapy company pioneering the development of T cell receptor (TCR) guided natural killer (NK) cell immunotherapies for the treatment of solid cancers. The company's proprietary TCR-NK platform is designed to combine the high-precision targeting of TCRs with the potent, innate anti-tumor activity of NK cells. This approach aims to overcome the challenges associated with treating solid tumors. Zelluna is focused on creating a new generation of allogeneic, "off-the-shelf" cell therapies. The mission is to deliver transformative and potentially curative treatments for patients with advanced solid cancers, addressing a significant unmet medical need.

Recent filings

Filing Released Lang Actions
Zelluna ASA - Grant of Share Options under Long-Term Incentive Program
Share Issue/Capital Change Classification · 95% confidence The document explicitly announces the 'Grant of Share Options under Long-Term Incentive Program' to employees and board members, detailing the number of options, vesting schedules, and exercise prices. This action involves the issuance of securities (options) to insiders and employees, which directly relates to capital structure changes and insider transactions. While it involves management (CEO, CFO), the core subject is the grant of options. This fits best under 'Capital/Financing Update' (CAP) as it relates to equity compensation and capital structure, or potentially 'Director's Dealing' (DIRS) due to insider grants, but CAP is broader for incentive programs. However, looking closely at the definitions, 'SHA' is 'Share Issue/Capital Change', and 'POS' is 'Transaction in Own Shares'. Since this is an option grant, which is a commitment to issue shares later, it is a form of capital change. Given the focus on executive/employee compensation via equity, it is closely related to insider transactions (DIRS) or capital changes (SHA). Since the document details grants to primary insiders (CEO, CFO, etc.), it strongly aligns with insider transaction reporting requirements, even if it's an option grant rather than a direct purchase/sale. However, the most specific category for executive/director compensation details is 'DEF 14A' (Remuneration Information), but this document is about *granting* options, not the full remuneration report. The closest fit among the provided options for an announcement detailing the issuance of stock options to insiders and employees is often categorized under insider transactions or capital changes. Given the explicit listing of insider grants (CEO, CFO), 'DIRS' (Director's Dealing) is a strong candidate, as option grants are often reported as insider transactions. Alternatively, 'CAP' (Capital/Financing Update) covers fundraising and capital structure changes. Since this is a specific grant announcement detailing insider participation, I will classify it as DIRS, as insider equity grants are a key component of director/insider reporting, although CAP is also plausible. Re-evaluating: The document is a formal announcement of an equity incentive program grant, which is a form of compensation and capital management. Since it details specific grants to primary insiders, DIRS is appropriate for reporting insider activity. If it were a general announcement about the program structure without specific insider grants, CAP might be better. Given the explicit listing of CEO/CFO grants, DIRS is the most precise fit for regulatory disclosure of insider activity.
2025-07-03 English
Disclosure of share transfer from Inven2 AS
Major Shareholding Notification Classification · 99% confidence The document explicitly details a 'Disclosure of share transfer' involving a major shareholder (Inven2 AS) transferring shares to inventors. It reports the number of shares transferred, the resulting holding percentage (10.79%), and the date of the transaction. This content directly relates to changes in significant share ownership or insider/major shareholder transactions. Since it is a disclosure about a transaction involving shares by a major shareholder, it aligns best with Major Shareholding Notification (MRQ) or potentially Director's Dealing (DIRS) if Inven2 AS was a director, but given the context of reporting a change in holding percentage after a transfer, MRQ is the most appropriate fit for tracking significant ownership changes. It is not an earnings release, annual report, or a general regulatory announcement fallback (RNS) because it fits a specific category.
2025-06-25 English
Disclosure of Shareholding - Gjelsten Holding AS
Major Shareholding Notification Classification · 99% confidence The document explicitly details a change in shareholding percentage for Gjelsten Holding AS in Zelluna ASA, noting that the ownership fell below the 5% threshold due to dilution from a private placement. This type of notification, concerning changes in significant share ownership levels crossing predefined thresholds, directly matches the definition for Major Shareholding Notification (MRQ). The reference to the Norwegian Securities Trading Act Section 4-3 confirms this is a mandatory disclosure regarding ownership stake changes.
2025-05-27 English
ZLNA - New registered share capital
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces a change in the company's registered share capital following a resolution by the Board of Directors to issue new shares against an option exercise fee. The title is "ZLNA - New registered share capital". This directly relates to changes in the company's capital structure, specifically the issuance of new shares. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). The document is short and is an announcement of a completed capital action, not a general regulatory filing (RNS) or a report publication announcement (RPA).
2025-05-27 English
ZLNA - Issuance of shares through set-off of option exercise fee
Share Issue/Capital Change Classification · 98% confidence The document explicitly discusses the resolution by the Board of Directors to issue new shares to settle an option exercise fee. Key phrases are 'Issuance of shares through set-off of option exercise fee' and 'Board of Directors has today resolved to issue 227,096 new shares'. This action directly relates to a change in the company's capital structure through the issuance of new stock, which aligns precisely with the definition of 'Share Issue/Capital Change' (SHA). It is not a general financing update (CAP) but a specific transaction involving share issuance.
2025-05-24 English
Zelluna ASA Reports First Quarter 2025 Financial Results and Provides General Business Update
Investor Presentation Classification · 95% confidence The document is a 'First Quarter 2025 Business Update and Financial Results' presentation for Zelluna ASA. It contains detailed slides on business milestones, technology pipelines, and financial performance (P&L, cash, and liquidity). As it is a slide deck presentation intended for investors to communicate quarterly progress and financial data, it falls under the 'Investor Presentation' category. Q1 2025
2025-05-08 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.